key: cord-0714934-rvpqcnfz
authors: Gao, Jia C.; Hood, Channing; Safai, Bijan; Marmon, Shoshana
title: Evidence for the Use of Mouthwash as a Preprocedural Preventive Measure Against COVID-19: Should We Rinse and Repeat?
date: 2021-12-23
journal: JAAD Int
DOI: 10.1016/j.jdin.2021.12.002
sha: 828a5c153e7a0612ae0fcffa42fc58d01574c44e
doc_id: 714934
cord_uid: rvpqcnfz

nan

Despite the effectiveness of vaccines in limiting severe illness, hospitalization, and death due to 26 COVID-19, the prevention of viral transmission has proven to be a much more elusive target. The 27 coronavirus, enriched in the upper airway, may spread by droplet and aerosol even in the absence 28 of symptomatic disease. Research and guidance from otolaryngology and dentistry, specialties at 29 particularly high risk of exposure, recommend that in addition to the use of standard infection 30 control measures, patients are given a preprocedural mouth rinse in the outpatient setting. 1,2,3 As 31 dermatologists, we regularly work in close proximity to patients' mouths when performing 32 biopsies on the face and mucosa or injecting lip and jawline filler. Here, we discuss the safety and 33 efficacy of commonly used oral rinse agents in reducing SARS-CoV-2 viral load and examine a 34 potential role for this preventative measure in routine dermatological practice (Table I) . 

Although it has 45 demonstrated activity against many enveloped viruses, its efficacy against SARS-CoV-2 remains 46 inconclusive. Overall, data supporting the use of CHX is considerably less compelling than References 68 1. Vergara-Buenaventura A, Castro-Ruiz C. Use of mouthwashes against COVID-19 in 69 dentistry

Efficacy of commercial mouth-rinses on SARS-72

CoV-2 viral load in saliva: randomized control trial in Singapore

Can povidone 75 iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial 76 and community transmission during the COVID-19 pandemic? An evidence-based

Differential Effects of Antiseptic Mouth Rinses on 79